Biotech Co. Celldex Completes $90M Curagen Buy
The two companies have signed a definitive agreement to merge, allowing Curagen to become a wholly owned subsidiary of Celldex, a joint statement released Thursday said.
Needham, Mass.-based Celldex purchased Curagen for $93.5 million, according to the companies.
Celldex and Curagen are merging to take advantage of complementary technologies they use to develop cancer drugs, a Celldex spokesman said. Both companies...
To view the full article, register now.